Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| ATHERSYS, INC / NEWATHX · Entity 95922 | Chief Financial Officer | June 17, 2022 | June 21, 2022 |
| SCYNEXIS INCSCYX · Entity 7194 | Chief Financial Officer | January 29, 2026 | February 02, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
ATHERSYS, INC / NEW
Report date June 17, 2022 · Filed June 21, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 143,290 |
Reported balance
After 2022-06-17 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2022-06-17 · Tax withholding · Disposed 624 · Balance 143,290 F1: Shares withheld from the quarterly vesting of annual restricted stock unit awards related to the tax withholding obligation. F2: Securities beneficially owned are comprised of (1) 43,290 shares of common stock owned and (2) unvested restricted stock units aggregating 100,000 related to annual awards, which vest quarterly over a four-year period from date of grant. |
Filing footnotes · ownership attribution and instrument terms
F1: Shares withheld from the quarterly vesting of annual restricted stock unit awards related to the tax withholding obligation.
F2: Securities beneficially owned are comprised of (1) 43,290 shares of common stock owned and (2) unvested restricted stock units aggregating 100,000 related to annual awards, which vest quarterly over a four-year period from date of grant.
SCYNEXIS INC
Report date January 29, 2026 · Filed February 02, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 398,529 |
Reported balance
After 2026-01-29 transaction · row 1
1 source rowRow 1 · 2026-01-29 · Grant · Acquired 129,833 · Balance 398,529 F1: Represents restricted stock units that vest one third per year over three years as measured from February 28, 2026. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents restricted stock units that vest one third per year over three years as measured from February 28, 2026.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 29, 2026 Filed Feb 2, 2026 21:03 UTC | SCYNEXIS INC SCYX · Entity 7194 | GrantCommon Stock | 129,833 | $0.00 | $0.00 |
DisclosureSEC source: 0001178253-26-000004 · ownership.xml · nonDerivative · entry 1 Macleod ivor · CIK 0001800734 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 398,529 F1 · shares: Represents restricted stock units that vest one third per year over three years as measured from February 28, 2026. Read SEC document |
| January 23, 2025 Filed Jan 27, 2025 21:03 UTC | SCYNEXIS INC SCYX · Entity 7194 | GrantEmployee Stock Option (Right to Buy) · Derivative | 138,767 | $0.00 Strike: $1.08 | $0.00 |
DisclosureSEC source: 0000950170-25-009173 · ownership.xml · derivative · entry 2 Macleod ivor · CIK 0001800734 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 138,767 Underlying: Common Stock · 138,767 shares Expires 2035-01-22 F2 · derivative.exercise_date: 1/48th of the shares subject to the option vest monthly for 48 months as measured from January 23, 2025. Read SEC document |
| January 23, 2025 Filed Jan 27, 2025 21:03 UTC | SCYNEXIS INC SCYX · Entity 7194 | GrantCommon Stock | 92,511 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-009173 · ownership.xml · nonDerivative · entry 1 Macleod ivor · CIK 0001800734 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 260,696 F1 · shares: Represents restricted stock units that vest one third per year over three years as measured from February 28, 2025. Read SEC document |
| January 26, 2024 Filed Jan 30, 2024 21:01 UTC | SCYNEXIS INC SCYX · Entity 7194 | GrantEmployee Stock Option (Right to Buy) · Derivative | 215,515 | $0.00 Strike: $1.86 | $0.00 |
DisclosureSEC source: 0000950170-24-008806 · ownership.xml · derivative · entry 2 Macleod ivor · CIK 0001800734 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 215,515 Underlying: Common Stock · 215,515 shares Expires 2034-01-25 F3 · derivative.exercise_date: 1/48th of the shares subject to the option vest monthly for 48 months as measured from February 15, 2024. Read SEC document |
| January 26, 2024 Filed Jan 30, 2024 21:01 UTC | SCYNEXIS INC SCYX · Entity 7194 | GrantCommon Stock | 143,675 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-008806 · ownership.xml · nonDerivative · entry 1 Macleod ivor · CIK 0001800734 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 160,185 F1 · shares: Represents restricted stock units that vest one third per year over three years as measured from February 15, 2024. F2 · balance_after: Includes 1,510 shares of common stock acquired under the 2014 Employee Stock Purchase Plan in September 2023. Read SEC document |
| October 24, 2022 Filed Oct 26, 2022 20:09 UTC | SCYNEXIS INC SCYX · Entity 7194 | GrantStock Option (Right to Buy) · Derivative | 170,000 | $0.00 Strike: $2.22 | $0.00 |
DisclosureSEC source: 0001209191-22-054618 · doc4.xml · derivative · entry 2 Macleod ivor · CIK 0001800734 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 170,000 Underlying: Common Stock · 170,000 shares Expires 2032-10-23 F2 · derivative.exercise_date: 25% of the shares subject to this option vests on the one-year anniversary of the grant date with the remainder vesting in equal monthly installments for thirty-six (36) months thereafter, provided the executive continues to provide continuous services to us. Read SEC document |
| October 24, 2022 Filed Oct 26, 2022 20:09 UTC | SCYNEXIS INC SCYX · Entity 7194 | GrantCommon Stock | 15,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-054618 · doc4.xml · nonDerivative · entry 1 Macleod ivor · CIK 0001800734 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 F1 · shares: Represents restricted stock units that vest one third per year over three years on the anniversary of the date of grant. Read SEC document |
| June 17, 2022 Filed Jun 21, 2022 18:00 UTC | ATHERSYS, INC / NEW ATHX · Entity 95922 | Tax withholdingCommon Stock | 624 | $0.28 | $174.72 |
DisclosureSEC source: 0001368148-22-000081 · wf-form4_165584883465074.xml · nonDerivative · entry 1 Macleod ivor · CIK 0001800734 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 143,290 F1 · shares: Shares withheld from the quarterly vesting of annual restricted stock unit awards related to the tax withholding obligation. F2 · balance_after: Securities beneficially owned are comprised of (1) 43,290 shares of common stock owned and (2) unvested restricted stock units aggregating 100,000 related to annual awards, which vest quarterly over a four-year period from date of grant. Read SEC document |
| March 17, 2022 Filed Mar 18, 2022 16:11 UTC | ATHERSYS, INC / NEW ATHX · Entity 95922 | Tax withholdingCommon Stock | 1,292 | $0.83 | $1,072.36 |
DisclosureSEC source: 0001368148-22-000026 · wf-form4_164763422702664.xml · nonDerivative · entry 1 Macleod ivor · CIK 0001800734 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 143,914 F1 · shares: Shares withheld from the quarterly vesting of annual restricted stock unit awards related to the tax withholding obligation. F2 · balance_after: Securities beneficially owned are comprised of (1) 35,580 shares of common stock owned and (2) unvested restricted stock units aggregating 108,334 related to annual awards, which vest quarterly over a four-year period from date of grant. Read SEC document |
| December 17, 2021 Filed Dec 17, 2021 18:00 UTC | ATHERSYS, INC / NEW ATHX · Entity 95922 | Tax withholdingCommon Stock | 1,377 | $1.00 | $1,377.00 |
DisclosureSEC source: 0001368148-21-000131 · wf-form4_163978203167548.xml · nonDerivative · entry 1 Macleod ivor · CIK 0001800734 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 145,206 F1 · shares: Shares withheld from the quarterly vesting of annual restricted stock unit awards related to the tax withholding obligation. F2 · balance_after: Securities beneficially owned are comprised of (1) 28,539 shares of common stock owned and (2) unvested restricted stock units aggregating 116,667 related to annual awards, which vest quarterly over a four-year period from date of grant. Read SEC document |
| November 17, 2021 Filed Nov 17, 2021 11:16 UTC | ATHERSYS, INC / NEW ATHX · Entity 95922 | PurchaseCommon Stock | 15,000 | $1.18 | $17,706.00 |
DisclosureSEC source: 0001368148-21-000122 · wf-form4_163716576150072.xml · nonDerivative · entry 1 Macleod ivor · CIK 0001800734 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 146,583 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased on the open market in multiple transactions at prices ranging from $1.16 to $1.20. Full information regarding the number of shares sold at each separate price is available upon request by the Commission staff, Athersys, Inc. or a security holder of Athersys, Inc. Read SEC document |
| September 17, 2021 Filed Sep 21, 2021 16:55 UTC | ATHERSYS, INC / NEW ATHX · Entity 95922 | Tax withholdingCommon Stock | 1,750 | $1.47 | $2,572.50 |
DisclosureSEC source: 0001368148-21-000108 · wf-form4_163225768618150.xml · nonDerivative · entry 1 Macleod ivor · CIK 0001800734 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 131,583 F1 · shares: Shares withheld from the quarterly vesting of annual restricted stock unit awards related to the tax withholding obligation. F2 · balance_after: Securities beneficially owned are comprised of (1) 6,583 shares of common stock owned and (2) unvested restricted stock units aggregating 125,000 related to annual awards, which vest quarterly over a four-year period from date of grant. Read SEC document |
| June 11, 2021 Filed Jun 15, 2021 17:43 UTC | ATHERSYS, INC / NEW ATHX · Entity 95922 | GrantStock Option (right to purchase) · Derivative | 300,000 | $0.00 Strike: $1.63 | $0.00 |
DisclosureSEC source: 0001368148-21-000068 · wf-form4_162379334778477.xml · derivative · entry 2 Macleod ivor · CIK 0001800734 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 300,000 Underlying: Common Stock · 300,000 shares Expires 2031-06-11 F3 · derivative.exercise_date: Award of an annual stock option. The option vests ratably on a quarterly basis over a four-year period. Read SEC document |
| June 11, 2021 Filed Jun 15, 2021 17:43 UTC | ATHERSYS, INC / NEW ATHX · Entity 95922 | GrantCommon Stock | 133,333 | $0.00 | $0.00 |
DisclosureSEC source: 0001368148-21-000068 · wf-form4_162379334778477.xml · nonDerivative · entry 1 Macleod ivor · CIK 0001800734 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 133,333 F1 · shares: Award of annual restricted stock units, each of which represent a contingent right to receive one share of Athersys, Inc. common stock after vesting. The restricted stock units vest ratably on a quarterly basis over a four-year period. F2 · balance_after: Securities beneficially owned are comprised of unvested restricted stock units aggregating 133,333 related to annual awards, which vest quarterly over a four-year period from date of grant. Read SEC document |
| March 01, 2021 Filed Mar 2, 2021 16:35 UTC | ATHERSYS, INC / NEW ATHX · Entity 95922 | GrantEmployee Stock Option (right to purchase) · Derivative | 250,000 | $0.00 Strike: $2.17 | $0.00 |
DisclosureSEC source: 0001368148-21-000018 · wf-form4_161472086531051.xml · derivative · entry 1 Macleod ivor · CIK 0001800734 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 250,000 Underlying: Common Stock · 250,000 shares Expires 2031-03-01 F1 · derivative.exercise_date: Award of an employee stock option in connection with a retention agreement. The option vests one-third on May 1, 2022 and two-thirds on May 1, 2023, subject to employee's continued service through the vesting date. Vesting would be accelerated upon a termination of employee's employment without cause. Read SEC document |
| January 31, 2020 Filed Feb 3, 2020 12:52 UTC | ATHERSYS, INC / NEW ATHX · Entity 95922 | GrantEmployee Stock Option (right to purchase) · Derivative | 600,000 | $0.00 Strike: $1.36 | $0.00 |
DisclosureSEC source: 0001368148-20-000012 · wf-form4_158075236124234.xml · derivative · entry 1 Macleod ivor · CIK 0001800734 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 600,000 Underlying: Common Stock · 600,000 shares Expires 2030-01-31 F1 · shares: One-fourth of the option vests on the one-year anniversary date of the grant and the remainder vests in equal quarterly installments over the following three years. F1 · derivative.expiration_date: One-fourth of the option vests on the one-year anniversary date of the grant and the remainder vests in equal quarterly installments over the following three years. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.